Ularitide and other vasoactive substances in acute decompensated heart failure: a systematic review and meta-analysis of randomized, double-blinded clinical trials
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the RIGENERA trial): 10 years follow-up.
Speaker:
Associate Professor D. D'Amario (Novara, IT)
First transcatheter intracardiac shunt device to reduce left atrial pressure in heart failure with preserved ejection fraction; the REDUCE elevated levt atrial pressure in patients with heart failure